Market Cap 49.62M
Revenue (ttm) 30,000.00
Net Income (ttm) -11.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39,466.67%
Debt to Equity Ratio 0.00
Volume 310,500
Avg Vol 128,328
Day's Range N/A - N/A
Shares Out 107.82M
Stochastic %K 13%
Beta 2.76
Analysts Strong Buy
Price Target N/A

Company Profile

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a uni...

Industry: Biotechnology
Sector: Healthcare
Phone: 281 415 6576
Address:
1400 Broadfield Blvd., Suite 130, Houston, United States
johannn
johannn Sep. 12 at 2:28 PM
$IBO $PRPH $DSS $AEI Is history repeating itself, as it so often does? Take this move by the scammers at DSS IBO; it bears a suspicious resemblance to the scam PRPH investors were subjected to. A reverse split, a supposed reverse merger with a fraudulent company—Dr. Ashley, alias Zoar Ltd. In the PRPH case, the scam unfolded like this: just before the reverse split, the reverse takeover was hyped up by "pumpers," drawing in opportunists eager to buy the stock. This led to the sale of millions of non-existent shares—shares that PRPH then made "real" by issuing new ones. The millions raised were used to pay off fabricated debts but, naturally, ended up in the scammers' pockets. The SEC simply lets stock market scammers operate unchecked while taking action against non-listed fraudsters—after all, they have to show *something* to prove they are cracking down on scams. Just look at the PRPH share price now: $0.02, and no longer listed on Nasdaq.
1 · Reply
topstockalerts
topstockalerts Sep. 11 at 10:28 PM
$IBO there’s a quiet confidence to this move.
0 · Reply
flychicken1991
flychicken1991 Sep. 11 at 8:41 PM
$IBO Negative (80%): IBO's stock price is likely to face near-term selling pressure as investors apply a larger liquidity and execution-risk discount to the sharply reduced post-split share base and assess whether additional equity financing could follow. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/dd69b48d3bb6496c/ibo-impact-biomedical-to-effect-1-for-12-62-reverse-stock-split?utm_source=stocktwits&utm_medium=story_url
0 · Reply
johannn
johannn Sep. 9 at 11:28 AM
$AEI $DSS $IBO $HWH Well, Chan—that sewer rat—thanks you for buying up some of his junk DSS Inc. shares. On June 3, 2026, he held... 26,464,246.00 shares—on paper, at least. https://www.sec.gov/Archives/edgar/data/1261725/000149315226032713/xslSCHEDULE_13D_X02/primary_doc.xml On September 3, 2026, he still held... 26,311,715.00 shares. https://www.sec.gov/Archives/edgar/data/1261725/000149315226041836/xslSCHEDULE_13D_X02/primary_doc.xml On September 3, 2026, Chan Heng Fai sold 21,852 shares of the Issuer's common stock at a sale price of $0.82 per share. We’ll find out soon enough if he’s sold any more—oh right, how does the saying go again? When an insider sells... These 21,852 shares of the Issuer's common stock are registered shares, not part of the millions of stolen unregistered ones. He also plans to dump AEI shares.https://www.sec.gov/Archives/edgar/data/1261725/000149315226040064/xsl144X01/primary_doc.xml
0 · Reply
RiseAboveAll752
RiseAboveAll752 Sep. 8 at 11:50 AM
$IBO .64 this morning
1 · Reply
johannn
johannn Sep. 8 at 10:02 AM
$DSS $IBO $AEI Keep dreaming, there will be no positive news; these fake companies of the Chinese sewer rat Chan are only there to steal investors' money. The exercise prices $0.74(1) $0.93(2) are marked so that the warrants can be exercised and the dilution of the remaining real investors is getting worse and worse. In any case, you got 5 likes, I probably won't get any. https://www.sec.gov/Archives/edgar/data/771999/000149315226032712/xslF345X06/ownership.xml
1 · Reply
topstockalerts
topstockalerts Sep. 4 at 8:39 PM
$IBO this one earned a closer look today
0 · Reply
RiseAboveAll752
RiseAboveAll752 Sep. 4 at 8:34 PM
$IBO $GIPR there goes GIPR
0 · Reply
RiseAboveAll752
RiseAboveAll752 Sep. 4 at 6:27 PM
$IBO someone trying to send this like $GIPR the other day ww
0 · Reply
ParkdaleTrader
ParkdaleTrader Sep. 4 at 6:14 PM
0 · Reply
Latest News on IBO
Impact BioMedical Quarterly report: Q2 2026

Aug 7, 2026, 7:00 AM EDT - 5 weeks ago

Impact BioMedical Quarterly report: Q2 2026


Impact BioMedical Quarterly report: Q1 2026

May 12, 2026, 7:00 AM EDT - 4 months ago

Impact BioMedical Quarterly report: Q1 2026


Impact BioMedical Annual report: Q4 2025

Mar 11, 2026, 7:00 AM EDT - 6 months ago

Impact BioMedical Annual report: Q4 2025


Why Is Impact BioMedical Stock (IBO) Up Today?

2026-03-05T13:17:27.000Z - 6 months ago

Why Is Impact BioMedical Stock (IBO) Up Today?

DSS


Impact BioMedical Quarterly report: Q3 2025

Nov 7, 2025, 4:00 PM EST - 10 months ago

Impact BioMedical Quarterly report: Q3 2025


Impact BioMedical Proxy statement: Proxy Filing

Sep 22, 2025, 8:00 AM EDT - 11 months ago

Impact BioMedical Proxy statement: Proxy Filing


Impact BioMedical announces 3F U.S. patent issue

2025-08-18T12:40:35.000Z - 1 year ago

Impact BioMedical announces 3F U.S. patent issue


Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue

Aug 18, 2025, 8:30 AM EDT - 1 year ago

Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue


Impact BioMedical Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Impact BioMedical Quarterly report: Q2 2025


Why Is Impact BioMedical Stock (IBO) Up 200% Today?

2025-06-24T01:29:00.000Z - 1 year ago

Why Is Impact BioMedical Stock (IBO) Up 200% Today?


Impact BioMedical Quarterly report: Q1 2025

May 14, 2025, 4:00 PM EDT - 1 year ago

Impact BioMedical Quarterly report: Q1 2025


Impact BioMedical Annual report: Q4 2024

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Impact BioMedical Annual report: Q4 2024


Impact Biomedical Inc. Announcement Stock Activity/Pricing

Mar 21, 2025, 2:38 PM EDT - 1 year ago

Impact Biomedical Inc. Announcement Stock Activity/Pricing


DSS announces sale of Celios to Impact BioMedical

2025-02-26T13:41:33.000Z - 1 year ago

DSS announces sale of Celios to Impact BioMedical

DSS


Impact BioMedical Inc. to Present at The Microcap Conference

Jan 23, 2025, 4:30 PM EST - 1 year ago

Impact BioMedical Inc. to Present at The Microcap Conference


Impact BioMedical Quarterly report: Q3 2024

Nov 12, 2024, 4:00 PM EST - 1 year ago

Impact BioMedical Quarterly report: Q3 2024


Impact BioMedical announces completion of IPO

2024-10-07T12:42:48.000Z - 1 year ago

Impact BioMedical announces completion of IPO


Impact BioMedical announces 3F US patent issue

2024-09-26T12:37:46.000Z - 1 year ago

Impact BioMedical announces 3F US patent issue


johannn
johannn Sep. 12 at 2:28 PM
$IBO $PRPH $DSS $AEI Is history repeating itself, as it so often does? Take this move by the scammers at DSS IBO; it bears a suspicious resemblance to the scam PRPH investors were subjected to. A reverse split, a supposed reverse merger with a fraudulent company—Dr. Ashley, alias Zoar Ltd. In the PRPH case, the scam unfolded like this: just before the reverse split, the reverse takeover was hyped up by "pumpers," drawing in opportunists eager to buy the stock. This led to the sale of millions of non-existent shares—shares that PRPH then made "real" by issuing new ones. The millions raised were used to pay off fabricated debts but, naturally, ended up in the scammers' pockets. The SEC simply lets stock market scammers operate unchecked while taking action against non-listed fraudsters—after all, they have to show *something* to prove they are cracking down on scams. Just look at the PRPH share price now: $0.02, and no longer listed on Nasdaq.
1 · Reply
topstockalerts
topstockalerts Sep. 11 at 10:28 PM
$IBO there’s a quiet confidence to this move.
0 · Reply
flychicken1991
flychicken1991 Sep. 11 at 8:41 PM
$IBO Negative (80%): IBO's stock price is likely to face near-term selling pressure as investors apply a larger liquidity and execution-risk discount to the sharply reduced post-split share base and assess whether additional equity financing could follow. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/dd69b48d3bb6496c/ibo-impact-biomedical-to-effect-1-for-12-62-reverse-stock-split?utm_source=stocktwits&utm_medium=story_url
0 · Reply
johannn
johannn Sep. 9 at 11:28 AM
$AEI $DSS $IBO $HWH Well, Chan—that sewer rat—thanks you for buying up some of his junk DSS Inc. shares. On June 3, 2026, he held... 26,464,246.00 shares—on paper, at least. https://www.sec.gov/Archives/edgar/data/1261725/000149315226032713/xslSCHEDULE_13D_X02/primary_doc.xml On September 3, 2026, he still held... 26,311,715.00 shares. https://www.sec.gov/Archives/edgar/data/1261725/000149315226041836/xslSCHEDULE_13D_X02/primary_doc.xml On September 3, 2026, Chan Heng Fai sold 21,852 shares of the Issuer's common stock at a sale price of $0.82 per share. We’ll find out soon enough if he’s sold any more—oh right, how does the saying go again? When an insider sells... These 21,852 shares of the Issuer's common stock are registered shares, not part of the millions of stolen unregistered ones. He also plans to dump AEI shares.https://www.sec.gov/Archives/edgar/data/1261725/000149315226040064/xsl144X01/primary_doc.xml
0 · Reply
RiseAboveAll752
RiseAboveAll752 Sep. 8 at 11:50 AM
$IBO .64 this morning
1 · Reply
johannn
johannn Sep. 8 at 10:02 AM
$DSS $IBO $AEI Keep dreaming, there will be no positive news; these fake companies of the Chinese sewer rat Chan are only there to steal investors' money. The exercise prices $0.74(1) $0.93(2) are marked so that the warrants can be exercised and the dilution of the remaining real investors is getting worse and worse. In any case, you got 5 likes, I probably won't get any. https://www.sec.gov/Archives/edgar/data/771999/000149315226032712/xslF345X06/ownership.xml
1 · Reply
topstockalerts
topstockalerts Sep. 4 at 8:39 PM
$IBO this one earned a closer look today
0 · Reply
RiseAboveAll752
RiseAboveAll752 Sep. 4 at 8:34 PM
$IBO $GIPR there goes GIPR
0 · Reply
RiseAboveAll752
RiseAboveAll752 Sep. 4 at 6:27 PM
$IBO someone trying to send this like $GIPR the other day ww
0 · Reply
ParkdaleTrader
ParkdaleTrader Sep. 4 at 6:14 PM
0 · Reply
IntentionalTrades
IntentionalTrades Sep. 4 at 5:54 PM
$IBO Short play potential
0 · Reply
johannn
johannn Sep. 4 at 1:23 PM
$DSS $AEI $IBO $HWH Could it have something to do with my post that DSS said $0.50 was too little for an additional share issuance or have they already diluted enough with the warrant deal with Chan the Chinese sewer rat. Warrant for the purchase of common stock (2) 06/03/2026 J 16.554.055(2) 06/03/2026 03/26/2031 Common stock 16.554.055(2) $0.93(2) 16.554.055(3)(4) I See footnote(3) https://www.sec.gov/Archives/edgar/data/771999/000149315226032712/xslF345X06/ownership.xml
1 · Reply
johannn
johannn Sep. 4 at 10:43 AM
$DSS $AEI $HWH $IBO YES yes, what did the scammers say again when they cancelled a share offering? https://ap.lc/ckvLM . After careful review of current market conditions and deal terms, management and the Board of Directors concluded that proceeding with the offering at this time would not reflect the value DSS believes it is building for shareholders. The share price was exactly the same as on June 9, but they simply had to mislead investors into believing that no share issuance would take place because otherwise no one would fall into the trap.
1 · Reply
johannn
johannn Sep. 4 at 9:51 AM
$DSS $AEI $IBO $HWH It's always the same old story with these scammers: pump the stock with their in-house market maker Sentinel Brokers Company who sells non-existent shares that become existing after DSS issues new shares. The funds they steal are not used for business purposes but disappear into their own pockets. Sentinel Brokers Company: A FINRA-registered broker-dealer acting as a financial intermediary for institutional bond trading and equity markets. https://ap.lc/uMawX
1 · Reply
ParkdaleTrader
ParkdaleTrader Sep. 3 at 12:34 PM
0 · Reply
johannn
johannn Sep. 1 at 4:01 PM
$IBO Where did you get that Net income turned positive at about $791K TTM.^^ If their revenue is $10,000 over 6 months, all fabricated loans are never repaid with cash anyway, but are redeemed with worthless shares of the borrower. https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=320255377&type=PDF&symbol=IBO&cdn=19251071198863374ab54a194fef017a&companyName=Impact+BioMedical+Inc.&formType=10-Q&formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&dateFiled=2026-08-07
0 · Reply
johannn
johannn Aug. 28 at 2:12 PM
$DSS $AEI $IBO $HWH Aha, now I understand why the SEC does not take action against fraudulent listed companies: the more companies, whether fraudulent or legitimate, the more revenue for the SEC / US Treasury. https://ap.lc/HVORu https://ap.lc/JbWdt The US Securities and Exchange Commission (SEC) is indirectly fully funded by the financial sector itself, although this is channeled through the US government. Although the SEC is a government agency, it costs the US taxpayer nothing net. How the funding works exactly The cash flow consists of two consecutive steps: Revenue via fees: The SEC levies billions of dollars annually in registration fees and transaction fees on the financial markets. This money is paid by: Stock traders and stock exchanges (for every purchase or sale of shares and securities). Listed companies (for example, when they register new shares or merge). Investment advisors and investment funds that are required to register.
0 · Reply
johannn
johannn Aug. 26 at 2:43 PM
$AEI $DSS $IBO $HWH $124.9M total assets vs. only $2.8M liabilities, so these so-called total assets are Real Estate - Rental Properties, Net 29,083,594 Cash and Cash Equivalents $12,325,977; the rest of that amount consists of shares in sister companies that are so diluted and have lost 99.xx% of their value that investors no longer trade in these shares. Take IBO shares issued and outstanding 11,503,955 on December 31, 2024 as an example, with a price of $1.45. As of August 4, 2026, there were 107,821,231 shares of the registrant’s common stock, with a price of $0.44. So nearly 96 million shares have been added, which is nine times as many, and the price has dropped by only a third and is still an empty shell. This explanation applies to all of Alset’s sister companies; they have all dropped by 99.xx% and been diluted by the same amount, so that Alset/Chan has the majority to embezzle the raised capital into its own pockets. But you don’t have to listen to me.
0 · Reply
johannn
johannn Aug. 26 at 10:29 AM
$AEI $DSS $IBO $HWH For those considering buying this junk Alset AEI, Chan the sewer rat will gladly sell his free/stolen shares to you. https://www.sec.gov/Archives/edgar/data/1261725/000149315226040064/xsl144X01/primary_doc.xml
0 · Reply
ParkdaleTrader
ParkdaleTrader Aug. 20 at 1:41 PM
0 · Reply
johannn
johannn Aug. 19 at 5:22 PM
$IBO $DSS $AEI $HWH All fake companies invented by Chan the sewer rat are empty shells engaging in fake trade and giving loans to each other to give the illusion that something is happening, but nothing is happening; only, the money the scammers have collected disappears into their personal pockets. https://www.sec.gov/Archives/edgar/data/1834105/000149315226036601/form10-q.htm
0 · Reply